INDOUS — Indo US Bio-Tech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Indo US Bio-Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.492	1.9	11	10	59.3
Net Total Accounts Receivable
Net Total Receivables	234	328	202	150	145
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	468	599	731	867	1,207
Net Property, Plant And Equipment	78.8	87.3	105	102	117
Long Term Notes Receivable
Other Long Term Assets
Total Assets	556	695	845	978	1,331
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	123	123	175	163	395
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	171	150	217	193	406
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	385	545	627	785	925
Total Liabilities & Shareholders' Equity	556	695	845	978	1,331
Total Common Shares Outstanding